삼성서울병원

Ko En

유방내분비외과 유재민 교수

진료분야
유방암, 유방 악성 질환, 유방로봇수술, 유전성 유방암-난소암 증후군, 유방 양성종양 수술
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2019.08 성균관대학교 의과대학원 의학 박사 졸업
2016.08 성균관대학교 의과대학원 의학 석사 졸업
2007.02 영남대학교 의학과 졸업

경력

경력
2020.03 ~현재 삼성서울병원 진료조교수
2018.03 ~현재 삼성서울병원 기관윤리사무국 위원회 (IRB) 위원
2018.03 ~ 2020.02 삼성서울병원 임상조교수
2015.05 ~ 2018.02 삼성서울병원 임상강사
2012.04 ~ 2015.05 군의관
2008.03 ~ 2012.02 삼성서울병원 전공의
2007.03 ~ 2008.02 영남대병원 인턴

학회활동

학회활동
2019.06 ~ 현재 한국 유방암학회 임상시험위원회 위원
2019.05 ~ 현재 한국 유방암학회 국제 위원회 위원
2019.05 ~ 현재 한국 유방암학회 학술위원회 위원
2019.05 ~ 현재 한국 유방암학회 교육위원회 위원
2018.06 ~ 현재 대한 종양외과학회 정회원
2018.06 ~ 현재 한국 유방암학회 진료권고안위원회 위원(유전성 유방암)
2018.06 ~ 현재 대한 림프종학회 정회원
2015.01 ~ 현재 한국 유방암학회 정회원
2012.01 ~ 현재 대한 외과학회 회원

수상이력

수상이력
2019.03 Global Poster Presentation (미국 종양외과학회)
2019.02 Best oral presentation (우수 구연자상, 대한종양외과학회
2018.04 Young investigator award (젊은 의학자상, 한국 유방암학회)
2018.02 Best oral presentation (우수 구연자상, 대한 종양외과학회)
2017.05 Young investigator award (젊은 의학자상, 대한 외과학회)
2016.11 Best investigator award (우수 의학자상, 대한 외과학회)
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
    View PubMed
  • ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169 Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
    View PubMed
  • EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011 A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • NUTRIENTS 2019 10.3390/nu11010037 Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
    View PubMed
  • Breast Cancer Res Treat. /2018 Oct 22 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu JM1, Choi HJ, Kim I, Nam SJ, Kim SW, Yu J, Lee SK, Choi DH, Park YH, Kim JW, Seo JS, Park JH, Lee JE, Kim SW
  • Breast Cancer Res Treat./ 2018 Sep 14. Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer. Ryu JM1, Choi HJ, Kim I, Lee SK, Yu J, Kim JE, Kang BI, Lee JE, Nam SJ, Kim SW.
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e54 Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e50 Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.173 Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.222 Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • WORLD J SURG 2018 10.1007/s00268-017-4342-7 Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003 Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
    View PubMed
  • Breast Cancer Res Treat/. 2017 Dec Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society Ryu JM1, Yu J, Kim SI, Kim KS, Moon HG, Choi JE, Jeong J, Do Byun K, Nam SJ, Lee JE, Lee SK, Kim SW.
  • Breast/ 2017 Jun Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea Ryu JM1, Kang G, Nam SJ, Kim SW, Yu J, Lee SK, Bae SY, Park S, Paik HJ, Kim JW, Park SS, Lee JE, Kim SW.
  • Clin Breast Cancer 2017 Nov Predictive factors for nonsentinel lymph node metastasis in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Ryu JM1, SK Lee, JY Kim, HJ Paik, S Park, J Yu, SW Kim, JE Lee, SY, Bae, SW Han, YS Jung, SJ Nam
  • Clin Breast Cancer 2017 June Oncologic safety of immediate breast reconstruction in breast cancer patients who underwent neoadjuvant chemotherapy: Short-term outcomes of a matched case control study. JM Ryu1, S Park, HJ Paik, SJ Nam, SW Kim, SK Lee, J Yu, SY Bae, I Kim, SI Bang, GH Mun, JK Pyon, BJ Jeon, JE Lee
  • J Breast Cancer/2017 March Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study. Ryu JM1, Paik HJ, Park S, Yi HW, Nam SJ, Kim SW, Lee SK, Yu J, Bae SY, Lee JE.
  • World J Surg. 2016 Aug Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm. Ryu JM1, Nam SJ, Kim SW, Lee SK, Bae SY, Yi HW, Park S, Paik HJ, Lee JE.
  • Breast. 2016 Dec Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype. Alramadhan M1, Ryu JM, Rayzah M, Nam SJ, Kim SW, Yu J, Lee SK, Bae SY, Park S, Paik HJ, Lee JE
  • Breast Cancer Res Treat /2017 Feb Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society. Ryu JM1, HJ Lee, TI Yoon, ES Lee, SJ Lee, JH Jung, BJ Chae, SJ Nam, JE Lee, SK Lee, SY Bae, J Yu, SW Kim